This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takada, N. Articles by Nakagawara, A. Search for Related Content PubMed PubMed Citation Articles by Takada, N. Articles by Nakagawara, A.

Identification of a Transactivation Activity in the COOH-Terminal Region of p73 Which Is Impaired in the Naturally Occurring Mutants Found inHuman Neuroblastomas¹

Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba 260-8717 [N. T., T. O., S. I., A. N.]; Department of Pathology, Sapporo Medical College, Sapporo 060-8556 [S. I.]; and First Department of Surgery, Hokkaido University School of Medicine, Sapporo 060-8638 [N. T., S. T.], Japan

p73 is a recently cloned tumor suppressor gene that is highly homologous to p53, and the products of both possess similar functions in inhibiting cell growth and inducing apoptosis. Interestingly, the COOH-terminal region of p53 displays no significant homology with that of p73. Moreover, p73 has an additional segment at its COOH terminus. Recently, we have found two mutations of p73 with amino acid substitution (P405R and P425L) in primary neuroblastomas. Because the region (amino acid residues 382–491) contains a glutamine- and proline-rich domain, we hypothesized that it has a transactivation function, and the mutations found in tumors result in loss of function. To test it, we used the yeast GAL4 DNA-binding fusion system. Yeast transformants expressing a GAL4-p73(1–112) or a GAL4-p73(380–513) fusion protein were grown in SD medium lacking histidine and tryptophan and exhibited a significant induction of ß-galactosidase activity. Transient transfection experiments revealed that both of fusion proteins could induce the chloramphenicol acetyltransferase activity in mammalian cells, indicating that the COOH-terminal as well as NH₂-terminal regions of p73 had significantly high levels of transactivation activity. Furthermore, the former activity was severely impaired in two naturally occurring mutant forms found in neuroblastomas. These suggest that, unlike p53, p73 has two domains with transactivation function, one in the NH₂-terminal region and the other in the COOH-terminal region. Loss of function mutation in the latter might be involved in tumorigenesis and/or tumor progression.

This article has been cited by other articles:

				U. Nyman, P. Vlachos, A. Cascante, O. Hermanson, B. Zhivotovsky, and B. Joseph Protein Kinase C-Dependent Phosphorylation Regulates the Cell Cycle-Inhibitory Function of the p73 Carboxy Terminus Transactivation Domain Mol. Cell. Biol., April 1, 2009; 29(7): 1814 - 1825. [Abstract] [Full Text] [PDF]

				D. Goldschneider, K. Million, A. Meiller, H. Haddada, A. Puisieux, J. Benard, E. May, and S. Douc-Rasy The neurogene BTG2TIS21/PC3 is transactivated by {Delta}Np73{alpha} via p53 specifically in neuroblastoma cells J. Cell Sci., March 15, 2005; 118(6): 1245 - 1253. [Abstract] [Full Text] [PDF]

				S. Das, W. S. El-Deiry, and K. Somasundaram Regulation of the p53 Homolog p73 by Adenoviral Oncogene E1A J. Biol. Chem., May 9, 2003; 278(20): 18313 - 18320. [Abstract] [Full Text] [PDF]

				P. Ghioni, F. Bolognese, P. H. G. Duijf, H. van Bokhoven, R. Mantovani, and L. Guerrini Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains{dagger} Mol. Cell. Biol., December 15, 2002; 22(24): 8659 - 8668. [Abstract] [Full Text] [PDF]

				S. Ichimiya, T. Kojima, H. Momota, N. Kondo, T. Ozaki, A. Nakagawara, M. L. Toribio, M. Imamura, and N. Sato p73 Is Expressed in Human Thymic Epithelial Cells J. Histochem. Cytochem., April 1, 2002; 50(4): 455 - 462. [Abstract] [Full Text] [PDF]

				G. Fontemaggi, A. Gurtner, S. Strano, Y. Higashi, A. Sacchi, G. Piaggio, and G. Blandino The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and Differentiation Mol. Cell. Biol., December 15, 2001; 21(24): 8461 - 8470. [Abstract] [Full Text] [PDF]

				M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF]

				A. K. El-Naggar, S. Lai, G. L. Clayman, B. Mims, S. M. Lippman, M. Coombes, M. A. Luna, and G. Lozano p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas Carcinogenesis, May 1, 2001; 22(5): 729 - 735. [Abstract] [Full Text] [PDF]

				M Levrero, V De Laurenzi, A Costanzo, J Gong, J. Wang, and G Melino The p53/p63/p73 family of transcription factors: overlapping and distinct functions J. Cell Sci., January 5, 2000; 113(10): 1661 - 1670. [Abstract] [PDF]

				T. Ozaki, M. Naka, N. Takada, M. Tada, S. Sakiyama, and A. Nakagawara Deletion of the COOH-Terminal Region of p73{{alpha}} Enhances Both Its Transactivation Function and DNA-binding Activity but Inhibits Induction of Apoptosis in Mammalian Cells Cancer Res., December 1, 1999; 59(23): 5902 - 5907. [Abstract] [Full Text] [PDF]